vs
FTC Solar, Inc.（FTCI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是FTC Solar, Inc.的1.1倍（$35.5M vs $32.9M），FTC Solar, Inc.净利率更高（-110.7% vs -304.2%，领先193.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 148.9%），FTC Solar, Inc.自由现金流更多（$-8.4M vs $-47.3M），过去两年FTC Solar, Inc.的营收复合增速更高（61.6% vs 60.5%）
FTC Solar是全球领先的太阳能跟踪系统供应商，主要研发、生产和销售太阳能跟踪支架、配套组件及相关软件解决方案，服务于公用事业级、工商业光伏项目领域，业务覆盖全球主要市场，助力客户提升光伏发电效率、降低项目成本。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
FTCI vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.1倍
$32.9M
营收增速更快
RXRX
高出532.8%
148.9%
净利率更高
FTCI
高出193.5%
-304.2%
自由现金流更多
FTCI
多$38.9M
$-47.3M
两年增速更快
FTCI
近两年复合增速
60.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $32.9M | $35.5M |
| 净利润 | $-36.4M | $-108.1M |
| 毛利率 | 14.9% | 59.8% |
| 营业利润率 | -17.2% | -304.8% |
| 净利率 | -110.7% | -304.2% |
| 营收同比 | 148.9% | 681.7% |
| 净利润同比 | -197.4% | 39.6% |
| 每股收益（稀释后） | $-2.31 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTCIRXRX
| Q4 25 | $32.9M | $35.5M | ||
| Q3 25 | $26.0M | $5.2M | ||
| Q2 25 | $20.0M | $19.2M | ||
| Q1 25 | $20.8M | $14.7M | ||
| Q4 24 | $13.2M | $4.5M | ||
| Q3 24 | $10.1M | $26.1M | ||
| Q2 24 | $11.4M | $14.4M | ||
| Q1 24 | $12.6M | $13.8M |
净利润FTCIRXRX
| Q4 25 | $-36.4M | $-108.1M | ||
| Q3 25 | $-23.9M | $-162.3M | ||
| Q2 25 | $-15.4M | $-171.9M | ||
| Q1 25 | $-3.8M | $-202.5M | ||
| Q4 24 | $-12.2M | $-178.9M | ||
| Q3 24 | $-15.4M | $-95.8M | ||
| Q2 24 | $-12.2M | $-97.5M | ||
| Q1 24 | $-8.8M | $-91.4M |
毛利率FTCIRXRX
| Q4 25 | 14.9% | 59.8% | ||
| Q3 25 | 6.1% | -183.8% | ||
| Q2 25 | -19.6% | -4.9% | ||
| Q1 25 | -16.6% | -48.0% | ||
| Q4 24 | -29.1% | -181.4% | ||
| Q3 24 | -42.5% | 53.7% | ||
| Q2 24 | -20.5% | 36.2% | ||
| Q1 24 | -16.7% | 19.1% |
营业利润率FTCIRXRX
| Q4 25 | -17.2% | -304.8% | ||
| Q3 25 | -29.6% | -3327.6% | ||
| Q2 25 | -57.5% | -916.8% | ||
| Q1 25 | -50.8% | -1297.9% | ||
| Q4 24 | -101.7% | -4042.4% | ||
| Q3 24 | -147.8% | -377.1% | ||
| Q2 24 | -104.3% | -697.4% | ||
| Q1 24 | -99.3% | -698.4% |
净利率FTCIRXRX
| Q4 25 | -110.7% | -304.2% | ||
| Q3 25 | -92.0% | -3135.3% | ||
| Q2 25 | -77.2% | -894.2% | ||
| Q1 25 | -18.4% | -1373.3% | ||
| Q4 24 | -92.7% | -3935.5% | ||
| Q3 24 | -151.5% | -367.5% | ||
| Q2 24 | -107.1% | -676.6% | ||
| Q1 24 | -69.7% | -662.4% |
每股收益（稀释后）FTCIRXRX
| Q4 25 | $-2.31 | $-0.17 | ||
| Q3 25 | $-1.61 | $-0.36 | ||
| Q2 25 | $-1.18 | $-0.41 | ||
| Q1 25 | $-0.58 | $-0.50 | ||
| Q4 24 | $-0.95 | $-0.56 | ||
| Q3 24 | $-1.21 | $-0.34 | ||
| Q2 24 | $-0.97 | $-0.40 | ||
| Q1 24 | $-0.70 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.1M | $743.3M |
| 总债务越低越好 | $9.9M | $9.6M |
| 股东权益账面价值 | $-43.0M | $1.1B |
| 总资产 | $111.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资FTCIRXRX
| Q4 25 | $21.1M | $743.3M | ||
| Q3 25 | $24.4M | $659.8M | ||
| Q2 25 | $3.5M | $525.1M | ||
| Q1 25 | $5.9M | $500.5M | ||
| Q4 24 | $11.2M | $594.4M | ||
| Q3 24 | $8.3M | $427.6M | ||
| Q2 24 | $10.8M | $474.3M | ||
| Q1 24 | $14.0M | $296.3M |
总债务FTCIRXRX
| Q4 25 | $9.9M | $9.6M | ||
| Q3 25 | $16.6M | $11.9M | ||
| Q2 25 | $10.9M | $14.2M | ||
| Q1 25 | $10.2M | $16.4M | ||
| Q4 24 | $9.5M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益FTCIRXRX
| Q4 25 | $-43.0M | $1.1B | ||
| Q3 25 | $-13.7M | $1.0B | ||
| Q2 25 | $9.0M | $919.1M | ||
| Q1 25 | $15.5M | $933.9M | ||
| Q4 24 | $19.0M | $1.0B | ||
| Q3 24 | $30.4M | $524.6M | ||
| Q2 24 | $44.2M | $584.4M | ||
| Q1 24 | $55.2M | $401.2M |
总资产FTCIRXRX
| Q4 25 | $111.8M | $1.5B | ||
| Q3 25 | $111.5M | $1.4B | ||
| Q2 25 | $83.0M | $1.3B | ||
| Q1 25 | $84.1M | $1.3B | ||
| Q4 24 | $89.9M | $1.4B | ||
| Q3 24 | $91.7M | $726.5M | ||
| Q2 24 | $100.3M | $775.9M | ||
| Q1 24 | $115.0M | $557.8M |
负债/权益比FTCIRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | 1.20× | 0.02× | ||
| Q1 25 | 0.65× | 0.02× | ||
| Q4 24 | 0.50× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-8.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | -25.7% | -133.1% |
| 资本支出强度资本支出/营收 | 1.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-34.6M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流FTCIRXRX
| Q4 25 | $-8.0M | $-46.1M | ||
| Q3 25 | $-14.6M | $-117.4M | ||
| Q2 25 | $-2.3M | $-76.4M | ||
| Q1 25 | $-8.5M | $-132.0M | ||
| Q4 24 | $-16.7M | $-115.4M | ||
| Q3 24 | $-2.4M | $-59.2M | ||
| Q2 24 | $-3.8M | $-82.2M | ||
| Q1 24 | $-11.9M | $-102.3M |
自由现金流FTCIRXRX
| Q4 25 | $-8.4M | $-47.3M | ||
| Q3 25 | $-15.1M | $-117.6M | ||
| Q2 25 | $-2.5M | $-79.6M | ||
| Q1 25 | $-8.6M | $-133.8M | ||
| Q4 24 | $-17.0M | $-116.7M | ||
| Q3 24 | $-2.6M | $-63.8M | ||
| Q2 24 | $-4.5M | $-83.4M | ||
| Q1 24 | $-12.3M | $-109.0M |
自由现金流率FTCIRXRX
| Q4 25 | -25.7% | -133.1% | ||
| Q3 25 | -57.9% | -2272.5% | ||
| Q2 25 | -12.4% | -413.9% | ||
| Q1 25 | -41.2% | -907.4% | ||
| Q4 24 | -128.6% | -2567.7% | ||
| Q3 24 | -25.6% | -244.6% | ||
| Q2 24 | -39.2% | -578.5% | ||
| Q1 24 | -97.6% | -789.9% |
资本支出强度FTCIRXRX
| Q4 25 | 1.3% | 3.5% | ||
| Q3 25 | 1.7% | 4.7% | ||
| Q2 25 | 0.9% | 16.4% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 2.2% | 28.6% | ||
| Q3 24 | 2.2% | 17.5% | ||
| Q2 24 | 6.1% | 8.2% | ||
| Q1 24 | 3.4% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTCI
| Products | $26.2M | 80% |
| Services | $6.7M | 20% |
RXRX
暂无分部数据
